Feasibility Study of Presurgical Hormone Therapy (Anastrozole) in Breast Cancer Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Breast Cancer
Interventions
DRUG

Anastrozole

Participants will be instructed to take one tablet of anastrozole orally per day with fluids. This tablet will be taken at the same time every day. Participants will be given a drug diary to record drug administration and aid in drug compliance. Should the participant miss a dose they will be asked to record it in their diary and resume the normal dose schedule the next day.

Trial Locations (1)

K1H 8L6

The Ottawa Hospital, Ottawa

All Listed Sponsors
collaborator

Canadian Breast Cancer Foundation

OTHER

lead

Ottawa Hospital Research Institute

OTHER